YCBD (cbdMD) Short-Term Debt to Capital

Corporate company logo of cbdMD Inc. (YCBD)

cbdMD, Inc. (YCBD) operates by creating cannabidiol products in the US, where geopolitical risks are minimal, although inflation and raw material supply chain disruptions from Asia may slow development. This price chart featuring the 0.04 indicator illustrates the struggle for market share amid oversupply and intense pricing pressure. Meanwhile, its status as a reliable partner for athletes and benchmark product purification ensure the brand's leadership in retail.

Ratio of Short-Term Indebtedness to Capital: cbdmd.com (YCBD) for 07/04/2022 - 10/30/2026

Analytical breakdowns for cbdMD, Inc.

- stock quotes and analyst forecast:
Stock Price cbdMD, Inc.|YCBD - Fair Value Consensus
- business market valuation indicators:
Market Capitalization cbdMD Inc.|YCBD - Enterprise Value
- book capitalization information:
Net Assets per Single Share cbdMD|YCBD - Accounting Value of Company|Market Value to Book Value Ratio cbdmd.com|YCBD - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital cbdMD, Inc.|YCBD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio cbdMD, Inc.|YCBD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio cbdMD Inc.|YCBD - Long-Term Debt|Company Current Liabilities cbdMD|Quick Ratio cbdmd.com
- company profitability and valuation multiples indicators:
YCBD - Final Profit
Fundamental valuation:YCBD cbdMD
Brand item of cbdmd.com

This ratio reflects the dependence of liquidity on equity, where an increasing share of short-term loans signals default risk, while a decrease limits profit growth rates. For cbdMD, Inc. during the transformation of its retail model toward digital sales, the chart of short-term liabilities to equity becomes a key indicator of cost optimization efficiency and the business's financial stability.

Competitors of cbdMD, Inc. (YCBD)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital BHST (BioHarvest Sciences Inc.)|EXOZ - Short-Term Debt to Equity Ratio|Oramed Pharma - Short-Term Debt to Capital|ENTX: Short-Term Debt to Equity|HYFT: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio ABVC|Short-Term Debt to Equity Cumberland Pharmaceuticals Inc.|Short-Term Debt to Equity Ratio Quantum BioPharma Ltd. (QNTM)|Short-Term Debt to Capital FGEN|Telomir Pharmaceuticals Corp - Short-Term Debt to Capital Ratio|Rani Therapeutics Holdings, Inc. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital SNYR|Rallybio Corp. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Lexaria Bioscience LEXX|Pulmatrix Corp (PULM) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio PTHL|APM (Aptorum Group Ltd) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio lyratherapeutics.com (LYRA)|Short-Term Debt to Equity Ratio IBO (Impact BioMedical)|Short-Term Debt to Capital Coefficient tnfpharma.com|PainReform Limited - Short-Term Debt to Equity Ratio|Altamira Therapeutics Ltd (CYTO) - Current Liabilities to Capital|Lipella Pharmaceuticals - Short-Term Debt to Capital|optinose.com (OPTN) - Short-Term Debt to Equity Ratio|PIRS: Short-Term Debt to Capital|PROC (Procaps Group) - Short-Term Debt to Equity|PTPI (Petros) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio QLI (Qilian International Corp)|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP: Current Liabilities to Equity